Appointment
© GSK

GlaxoSmithKline: Insider Appointment

Six months ago, Andrew Witty, long-time CEO of Britains largest drug maker GlaxoSmithKline, announced he would retire in 2017. Now, GSK has named Emma Walmsley from inside the company as his successor.

Walmsley, who holds an MA in Classics and Modern Languages from Oxford University, is currently CEO of GSK Consumer Healthcare. She joined GSK in 2010 from L’Oreal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the UK, Europe and USA. From 2007 she was based in Shanghai as General Manager, Consumer Products for L’Oreal China. In 2016, she became a non-executive director of Diageo plc. 

Walmsley will join the GSK Board of Directors from 1 January 2017.